These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 3790187)

  • 1. General pharmacological properties of a low molecular weight heparin in rodents.
    Fantuz M; Bertoli D
    Arzneimittelforschung; 1986 Sep; 36(9):1366-8. PubMed ID: 3790187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toxic and mutagenic effects of a low molecular weight heparin in rats.
    Borelli G; Bertoli D
    Arzneimittelforschung; 1986 Aug; 36(8):1256-60. PubMed ID: 3535813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antithrombotic effect of OP/LMWH by subcutaneous route in rats.
    Fantuz M; Milani R; Andriuoli G; Mastacchi R; Barbanti M
    Arch Int Pharmacodyn Ther; 1986 Aug; 282(2):328-34. PubMed ID: 3767531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. General pharmacological properties of a new non-opiate antitussive: zipeprol (3024 CERM). II. Actions on the cardiovascular system, intestinal transit and central nervous system.
    Cosnier D; Hache J; Labrid C; Rispat G
    Arzneimittelforschung; 1976; 26(5):848-55. PubMed ID: 989357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. General pharmacology of recombinant human basic fibroblast growth factor.
    Okumura M; Yajima M; Nishimura T; Ikeda H; Nishimori T
    Arzneimittelforschung; 1996 Jul; 46(7):727-39. PubMed ID: 8842346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [General pharmacologic studies on the analgesic flupirtine].
    Jakovlev V; Achterrath-Tuckermann U; von Schlichtegroll A; Stroman F; Thiemer K
    Arzneimittelforschung; 1985; 35(1):44-55. PubMed ID: 4039152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological studies of mabuterol, a new selective beta 2-stimulant. II: Effects on the cardiovascular system and smooth muscle organs.
    Osada E; Murai T; Ishizaka Y; Sanai K
    Arzneimittelforschung; 1984; 34(11A):1641-51. PubMed ID: 6152157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. General pharmacological profile of the novel cholecystokinin-A antagonist loxiglumide.
    Saito T; Ukai K; Masuda T; Nakagawa T; Kimura K; Fujii M; Wakatsuki K; Saeki M; Kasai H
    Arzneimittelforschung; 1997 Dec; 47(12):1375-82. PubMed ID: 9450167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and pharmacological properties of new derivatives of 1-diphenylacetamide-2-butanol.
    Kolasa K; Kleinrok Z; Pietrasiewicz T; Czechowska G; Zejc A; Gajewczyk L
    Pol J Pharmacol Pharm; 1989; 41(5):475-81. PubMed ID: 2577062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Denzimol, a new anticonvulsant drug. II. General pharmacological activities.
    Graziani G; Cazzulani P; Luca C; Nava G; Testa R
    Arzneimittelforschung; 1983; 33(8):1161-8. PubMed ID: 6685494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peri- and postnatal, teratology and reproductive studies of a low molecular weight heparin in rats.
    Bertoli D; Borelli G
    Arzneimittelforschung; 1986 Aug; 36(8):1260-3. PubMed ID: 3778563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacology of lortalamine, a new potent non-tricyclic antidepressant.
    Depin JC; Betbeder-Matibet A; Bonhomme Y; Muller AJ; Berthelon JJ
    Arzneimittelforschung; 1985; 35(11):1655-62. PubMed ID: 4091869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacology of secoverine, a new spasmolytic agent with specific antimuscarinic properties. Part 2: General pharmacological properties.
    Zwagemakers JM; Claassen V
    Arzneimittelforschung; 1980; 30(9):1526-34. PubMed ID: 7193021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central effects of leukotriene C4 and D4 in rats and mice.
    Brus R; Krzeminski T; Juraszczyk Z; Kurcok A; Felinska W; Kozik W
    Biomed Biochim Acta; 1986; 45(9):1153-8. PubMed ID: 3814105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological studies on timiperone, a new neuroleptic drug Part II: General pharmacological properties.
    Yamasaki T; Kojima H; Tanaka M; Aibara S; Hirohashi M; Kasai Y; Tsubokawa M; Watanabe K; Akashi A
    Arzneimittelforschung; 1981; 31(4):707-15. PubMed ID: 6113834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and preliminary pharmacological investigation of the central action of derivatives of 3-aminomethyl-5-(p-chlorophenyl)-tetrahydrofuran-2-one and 2-aminomethyl-4-(p-chlorophenyl)-4-hydroxybutyric acid.
    Zabska R; Wilimowski M; Barczyńska J; Kedzierska-Goździk L; Wojewódzki W; Duś E; Rutkowska M; Szelag A
    Pol J Pharmacol Pharm; 1989; 41(1):77-87. PubMed ID: 2587440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. General pharmacological properties of the human corticotropin-releasing hormone corticorelin (human).
    Andoh K; Kimura T; Saeki I; Tabata R; Yamazaki S; Eguchi I; Hanazuka M; Horii D; Munt PL; Davis AS
    Arzneimittelforschung; 1994 Jun; 44(6):715-26. PubMed ID: 8053970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. General pharmacological properties of UFT, a new type of anti-cancer agent consisting of 1-(2-tetrahydrofuryl)-5-fluorouracil (FT) and uracil. I: Pharmacological analysis of the combined effect of FT and uracil.
    Yamamoto J; Toide K; Haruno A; Yoshimura Y; Unemi N
    Arzneimittelforschung; 1981; 31(8):1268-78. PubMed ID: 6794578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological properties of new 11H-indeno[1,2-b]-quinolin-11-one derivatives.
    Chojnacka-Wójcik E; Naparzewska A
    Pol J Pharmacol Pharm; 1982; 34(5-6):357-63. PubMed ID: 6892276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiorespiratory, sympathetic and biochemical responses to T-2 toxin in the guinea pig and rat.
    Feuerstein G; Goldstein DS; Ramwell PW; Zerbe RL; Lux WE; Faden AI; Bayorh MA
    J Pharmacol Exp Ther; 1985 Mar; 232(3):786-94. PubMed ID: 3973827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.